Display Settings:

Format

Send to:

Choose Destination
    Crit Care. 2007;11(1):113.

    Bolus or continuous hydrocortisone--that is the question.

    Source

    Clinic of Anesthesiology and Intensive Care Medicine, Charité, Universitätsmedizin Berlin, Campus Virchow-Klinikum & Campus Mitte, Berlin, Germany. steffen.weber-carstens@charite.de

    Abstract

    Constantly evolving treatment guidelines based on a growing body of randomized controlled trials are helping us to improve outcomes in sepsis. However, it must be borne in mind that proven benefit from individual sepsis treatments does not guarantee synergistic beneficial effects when new treatments are added to sepsis management. Indeed, unexpected harmful interactions are also possible. A good example of this is the conflict between intensive insulin therapy and 'low dose' hydrocortisone in septic shock. The goal of tight glycaemic control is made more complicated by steroid-induced hyperglycaemia. In their recent study, Loisa and coworkers demonstrate a measure that reduces the risk for this interaction. They found continuous infusion of hydrocortisone to be associated with fewer hyperglycaemic episodes and reduced staff workload compared with bolus application.

    PMID:
    17316466
    [PubMed - indexed for MEDLINE]
    PMCID: PMC2151867
    Free PMC Article

      Supplemental Content

      Click here to read

      Chemical compound information

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk